Reading Time: 6 minutesNew and effective treatments for MND are urgently needed and many scientists around the world are working towards this goal. Throughout 2024, we saw many
Category: Treatments
Clinical Trials Get involved with research Markers of Disease Progression MND Research Research we fund Treatments
UK clinical trial updates to look out for in 2025
Reading Time: 6 minutesNew and effective treatments for MND are urgently needed and many scientists around the world are working towards this. Throughout 2024, we saw many new
35th Symposium: Montreal Causes and disease mechanisms Events Markers of Disease Progression MND Research Models of MND News Symposium Treatments
Shining a light on the next generation of MND researchers
Reading Time: 5 minutesThe 35th International Symposium on ALS/MND, organised by the MND Association, was held on 6-8 December 2024 and welcomed over 1200 delegates to Montreal, Canada
35th Symposium: Montreal Clinical Trials Events Healthcare MND Research Research we fund Symposium Treatments
Finding treatments and improving care in MND
Reading Time: 7 minutesIt’s that time of year again when we’re counting down to the annual International Symposium on ALS/MND! This year marks the 35th Symposium, the largest scientific
Reading Time: 5 minutesIn July we hosted our annual event for early career researchers (ECRs) in the UK. MND EnCouRage UK is a two day event which aims
Reading Time: 5 minutesWhile we work hard for a cure, it is essential we support those living with MND now. Professor Chris McDermott, Professor of Translational Neurology at
Reading Time: 5 minutesBuilding relationships with key research institutes across the UK is vital in pushing research forward in the fight against MND. As of 31 December 2023,
Reading Time: 5 minutesDespite extensive research, the causes of MND remain largely unknown. Recent investigations have begun to shed light on the gut microbiome and whether it may
Reading Time: 10 minutesFor the purposes of this blog, ALS should be taken to mean ALS/MND. In September 2020 we published a blog article discussing Dr Rick Bedlack’s
Reading Time: 5 minutes"New drug reduces risk of death by 50%"
You may have seen this type of headline in news articles reporting on the outcome of clinical trials. Reading this headline can lead people to believe a potential drug is highly beneficial and has a real impact. However, it is important to delve a little deeper into the meaning of ‘risk of death’, the raw data behind it, and how it should be considered alongside other outcome measures of a trial to fully determine how effective a drug might be.